CN109223602A - The method for customizing of eye skin care item and eye maintenance method - Google Patents
The method for customizing of eye skin care item and eye maintenance method Download PDFInfo
- Publication number
- CN109223602A CN109223602A CN201811400907.1A CN201811400907A CN109223602A CN 109223602 A CN109223602 A CN 109223602A CN 201811400907 A CN201811400907 A CN 201811400907A CN 109223602 A CN109223602 A CN 109223602A
- Authority
- CN
- China
- Prior art keywords
- parts
- skin
- eye
- xylitol
- functional component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 56
- 238000012423 maintenance Methods 0.000 title claims abstract description 13
- 238000012512 characterization method Methods 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 230000000474 nursing effect Effects 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 115
- 230000037394 skin elasticity Effects 0.000 claims description 73
- 230000000694 effects Effects 0.000 claims description 71
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 66
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 64
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 64
- 239000000811 xylitol Substances 0.000 claims description 64
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 64
- 229960002675 xylitol Drugs 0.000 claims description 64
- 235000010447 xylitol Nutrition 0.000 claims description 64
- 239000006071 cream Substances 0.000 claims description 57
- 229930182478 glucoside Natural products 0.000 claims description 40
- 239000003813 safflower oil Substances 0.000 claims description 38
- 150000008131 glucosides Chemical class 0.000 claims description 37
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 36
- 235000006533 astragalus Nutrition 0.000 claims description 35
- 241001061264 Astragalus Species 0.000 claims description 34
- 210000004233 talus Anatomy 0.000 claims description 34
- 229930003427 Vitamin E Natural products 0.000 claims description 33
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 33
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 33
- 229940046009 vitamin E Drugs 0.000 claims description 33
- 239000011709 vitamin E Substances 0.000 claims description 33
- 235000019165 vitamin E Nutrition 0.000 claims description 33
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 32
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims description 32
- 229940035936 ubiquinone Drugs 0.000 claims description 32
- KZVAAIRBJJYZOW-VPENINKCSA-N (2r,3r,4s)-2-(hydroxymethyl)oxolane-3,4-diol Chemical compound OC[C@H]1OC[C@H](O)[C@H]1O KZVAAIRBJJYZOW-VPENINKCSA-N 0.000 claims description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 27
- 229940083987 anhydroxylitol Drugs 0.000 claims description 27
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 26
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims description 22
- 239000004615 ingredient Substances 0.000 claims description 22
- 235000007627 Caesalpinia Nutrition 0.000 claims description 21
- 241000522234 Caesalpinia Species 0.000 claims description 21
- 108010016626 Dipeptides Proteins 0.000 claims description 21
- 102000016942 Elastin Human genes 0.000 claims description 21
- 108010014258 Elastin Proteins 0.000 claims description 21
- 239000004348 Glyceryl diacetate Substances 0.000 claims description 21
- 235000021028 berry Nutrition 0.000 claims description 21
- 229920002549 elastin Polymers 0.000 claims description 21
- 235000019443 glyceryl diacetate Nutrition 0.000 claims description 21
- 239000011159 matrix material Substances 0.000 claims description 21
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 20
- 241000195493 Cryptophyta Species 0.000 claims description 20
- 244000068988 Glycine max Species 0.000 claims description 20
- 235000010469 Glycine max Nutrition 0.000 claims description 20
- 244000217433 Melampodium divaricatum Species 0.000 claims description 20
- 230000036564 melanin content Effects 0.000 claims description 20
- 230000002500 effect on skin Effects 0.000 claims description 19
- 230000007062 hydrolysis Effects 0.000 claims description 17
- 238000006460 hydrolysis reaction Methods 0.000 claims description 17
- 239000000049 pigment Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 13
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 13
- 229940106189 ceramide Drugs 0.000 claims description 13
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 13
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 13
- RRSSMGPWRZSFER-UHFFFAOYSA-N 4,4-diamino-N-benzylbutanamide Chemical compound NC(N)CCC(=O)NCC1=CC=CC=C1 RRSSMGPWRZSFER-UHFFFAOYSA-N 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 11
- 229930006000 Sucrose Natural products 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 9
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- 229920002498 Beta-glucan Polymers 0.000 claims description 8
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 8
- 229920002125 Sokalan® Polymers 0.000 claims description 8
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 8
- 229960001631 carbomer Drugs 0.000 claims description 8
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 8
- 229960000541 cetyl alcohol Drugs 0.000 claims description 8
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 8
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 7
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 7
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 7
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 7
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 claims description 7
- 229940055577 oleyl alcohol Drugs 0.000 claims description 7
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 7
- 229940042585 tocopherol acetate Drugs 0.000 claims description 7
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 5
- 239000004909 Moisturizer Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000686 essence Substances 0.000 claims description 4
- 230000001333 moisturizer Effects 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 239000000043 antiallergic agent Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 239000003002 pH adjusting agent Substances 0.000 claims description 3
- 229940100460 peg-100 stearate Drugs 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 claims description 2
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002270 dispersing agent Substances 0.000 claims description 2
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims 3
- 238000006297 dehydration reaction Methods 0.000 claims 3
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 17
- 230000005808 skin problem Effects 0.000 abstract description 13
- 206010013786 Dry skin Diseases 0.000 abstract description 8
- 235000002673 Dioscorea communis Nutrition 0.000 abstract description 7
- 241000544230 Dioscorea communis Species 0.000 abstract description 7
- 208000035753 Periorbital contusion Diseases 0.000 abstract description 7
- 230000037336 dry skin Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 216
- 238000012360 testing method Methods 0.000 description 79
- 239000000523 sample Substances 0.000 description 46
- 230000008859 change Effects 0.000 description 44
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 20
- 241001519517 Kappaphycus Species 0.000 description 18
- 206010040954 Skin wrinkling Diseases 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 17
- -1 alcohol radical glucoside Chemical class 0.000 description 15
- 230000006872 improvement Effects 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000008092 positive effect Effects 0.000 description 7
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 229940075946 dermatop Drugs 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- FNPXMHRZILFCKX-KAJVQRHHSA-N prednicarbate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)CC)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O FNPXMHRZILFCKX-KAJVQRHHSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 244000139010 Spilanthes oleracea Species 0.000 description 3
- 235000007892 Spilanthes oleracea Nutrition 0.000 description 3
- 229930003448 Vitamin K Natural products 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 210000000106 sweat gland Anatomy 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 description 3
- 229940046010 vitamin k Drugs 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 241000206572 Rhodophyta Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- BXOCHUWSGYYSFW-HVWOQQCMSA-N spilanthol Chemical compound C\C=C\C=C/CC\C=C\C(=O)NCC(C)C BXOCHUWSGYYSFW-HVWOQQCMSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 125000001655 ubiquinone group Chemical group 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical class CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 1
- DCRRVDXYSHOJEF-UHFFFAOYSA-N 4-amino-N-benzylbutanamide Chemical compound NCCCC(=O)NCC1=CC=CC=C1 DCRRVDXYSHOJEF-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 241001134782 Gigartinales Species 0.000 description 1
- 244000048443 Gomphrena celosioides Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001519524 Kappaphycus alvarezii Species 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241001474977 Palla Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000828356 Solieria <tachinid fly> Species 0.000 description 1
- 235000013474 Spilanthes acmella Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241001424341 Tara spinosa Species 0.000 description 1
- 241000719329 Trentepohlia Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 101800002700 Waglerin-1 Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JSXROLUNEDJZJE-UHFFFAOYSA-N acetic acid;phenol Chemical group CC(O)=O.OC1=CC=CC=C1 JSXROLUNEDJZJE-UHFFFAOYSA-N 0.000 description 1
- 230000002164 acetylcholinergic effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- BXOCHUWSGYYSFW-UHFFFAOYSA-N all-trans spilanthol Natural products CC=CC=CCCC=CC(=O)NCC(C)C BXOCHUWSGYYSFW-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000000179 crotalid venom Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 230000037377 skin turgor Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000037339 smooth wrinkles Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UUGXJSBPSRROMU-WJNLUYJISA-N ubiquinone-9 Chemical group COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O UUGXJSBPSRROMU-WJNLUYJISA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The present invention provides a kind of method for customizing of eye skin care item and eye maintenance methods, are related to the technical field of skin care item.The method for customizing of the eye skin care item includes: to match functional component according to the parameter of the characterization eye problems of customized objects, and the eye skin care item comprising the functional component are then made.The present invention uses the eye part skin problem of parameter characterization customized objects, so that the eye part skin problem of customized objects more intuitively can be reacted and be measured, then corresponding functional component, the eye part skin for solving the problems, such as customized objects for being directed to the eye skin care item produced more are matched according to parameter.The inventive concept of method for customizing based on above-mentioned eye skin care item, the present invention also provides a kind of eye maintenance methods, this method includes the skin care item nursing eye circumference skin being prepared using the preparation method of above-mentioned customization eye skin care item, this method can effectively alleviate eye circumference dry skin problem, restore eye circumference elasticity of skin and reduce wrinkle and black eye.
Description
Technical field
The present invention relates to technical field of skin care, method for customizing and eye maintenance more particularly, to a kind of eye skin care item
Method.
Background technique
Eyes are the positions for revealing the age earliest on the face, and vigorous eyes can allow whole face all to show younger.
But since eye part skin is most thin one of the skin of human body, the thickness on eye part skin surface layer is only the 1/3-1/5 of face, daily
Blink about 1000 times, and 14 groups of muscle of circumference of eyes are employed, cause eye circumference skin to be easier than the skin at other facial positions
Existing problem.
In acidity, have prevents from being dehydrated the water adipose membrane of the sweat of sweat gland secretion and fat composition, lubricates skin in general skin
The effect of injury of the external environment to skin is divided in skin, blocking part, is the natural protective film of skin.And circumference of eyes only has sebaceous glands
With abnormal sweat gland, it only has independent sweat gland without the distribution of sebum, thus water adipose membrane to the protective effect of eye part skin very
It is small.In addition eye part skin fat content is few, and lack flexibility fiber and collagen structure in skin corium, therefore eye part skin is easy to lose bullet
Property.Therefore there is allergy compared with influencing vulnerable to external factor, or even occur shifting to an earlier date aging phenomenon.
The nerve fibre and capillary distribution density of circumference of eyes are very high, enable the circulation and lymphatic system fortune of circumference of eyes
Row is slower, be easy to cause the feeling of fatigue of eye, and poor blood circulation will cause extravasated blood, causes eye dim.Experiment shows to lead to
It crosses and the test of eye circumference skin is carried out to Chinese women, the hemochrome protein content of palpebra inferior is higher than cheek, skin elasticity and cheek phase
Decline than.
Since eye part skin has the characteristics that above, daily life system is abnormal, in bad health and improper etc. with eye
Phenomena such as will causing eye part skin dimness, accelerated ageing, eye part skin relaxation, and along with black eye, eye pouch, canthus line,
The eye problems such as ocular edema, fat granule.
Further, due to extraneous factors and operating pressure and bad lives such as ultraviolet light irradiation, the radiation of long-time computer
Habit causes black eye, eye pouch, crow's feet and fat granule crowd gradually to increase.These eye part skin problems are listless to people,
The mental attitude of fatigue, while the more aging that seems.Show according to the study in China, there are eye circumference skin to ask by 50% or more women
The worry of topic, and with age, the crowd for the eye part skins problem such as black eye, wrinkle, eye pouch occur increases, therefore consumes
The effects of person gradually focuses on eye part skin nursing, seeks the beautification of cosmetics, repairs is to reach compact, fine and smooth, flexible
Eye skin state.
But an outstanding problem of existing eye cream is, single formula is not appropriate for owner, because of everyone gender
The climatic season of different, age difference, locating region or working environment difference, location is different, and living habit is different, this is all
It may cause single eye cream to be not quite similar to the effect of eye skin.Therefore, existing single formula eye cream unsuitable people
Class skin physiology nurses Dermatology and proposes otherness demand.It is a kind of to customize eye cream according to the eye problems of applicable object
Method is existing market needs.
In view of this, the present invention is specifically proposed.
Summary of the invention
The first object of the present invention is to provide a kind of method for customizing of eye skin care item, and this method alleviates the prior art
Present in lack there is the method for targetedly customizing eye cream for personalized eye problems.
The second object of the present invention is to provide a kind of eye maintenance method, and this method includes the above-mentioned customization eye of the right to use
The skin care item that the preparation method of skin care item is prepared nurse eye circumference skin.
In order to solve the above technical problems, spy of the present invention adopts the following technical scheme that
A kind of method for customizing of eye skin care item, comprising: function is matched according to the parameter of the characterization eye problems of customized objects
Ingredient is imitated, the eye skin care item comprising the functional component are then made.
Preferably, the eye problems include moisture content of skin, skin pigment content, skin elasticity, dermatoglyph degree and
One or more of skin smoothness.
Preferably, if moisture content of skin≤40C.U, A1 group functional component is matched；If 40C.U < moisture content of skin≤
60C.U matches A2 group functional component；If moisture content of skin > 60C.U, A3 group functional component is matched；
Preferably, the A1 group functional component, the A2 group functional component and the A3 group functional component be independently
Including one or more of ceramide, Xylitol-based glucoside, anhydro xylitol, xylitol；
Preferably, the A1 group component include: in parts by weight -5 parts of Cer NP, it is glucoside 5-6 parts Xylitol-based,
5-6 parts and xylitol 5-6 parts of anhydro xylitol；
Preferably, the A2 group component include: in parts by weight -3 parts of Cer NS, it is glucoside 3-5 parts Xylitol-based,
3-5 parts and xylitol 3-5 parts of anhydro xylitol；
Preferably, the A3 group component include: in parts by weight -2 parts of Cer EOS, it is glucoside 1-3 parts Xylitol-based,
1-3 parts and xylitol 1-3 parts of anhydro xylitol.
Preferably, with skin elasticity R2 value characterize skin elasticity, if value≤0.5 skin elasticity R2, matching B1 group effect at
Point；If 0.5 value≤0.7 < skin elasticity R2, B2 group functional component is matched；If skin elasticity R2 value > 0.7, B3 group effect is matched
Ingredient；
Preferably, the B1 group functional component, the B2 group functional component and the B3 group functional component be independently
Including tetrahydro methylpyrimidine carboxylic acid, safflower seed oil, golden button extract, Astragalus membranacus root extract, ubiquinone, vitamin E and water
Solve one or more of elastin laminin；
Preferably, the B1 group component includes: 0.5-1 parts of tetrahydro methylpyrimidine carboxylic acid, safflower seed oil 3-4 in parts by weight
Part, golden 3-4 parts of button extract, 3-4 parts of Astragalus membranacus root extract, 3-4 parts of ubiquinone, 3-4 parts of vitamin E and hydrolyzed elastin
4-5 parts of albumen；
Preferably, the B2 group component includes: 0.2-0.5 parts of tetrahydro methylpyrimidine carboxylic acid, safflower seed oil in parts by weight
2-3 parts, golden 2-3 parts of button extract, 2-3 parts of Astragalus membranacus root extract, 2-3 parts of ubiquinone, 2-3 parts of vitamin E and hydrolysis bullet
2-4 parts of albumen of property；
Preferably, the B3 group component includes: 0.1-0.2 parts of tetrahydro methylpyrimidine carboxylic acid, safflower seed oil in parts by weight
1-2 parts, golden 1-2 parts of button extract, 1-2 parts of Astragalus membranacus root extract, 1-2 parts of ubiquinone, 1-2 parts of vitamin E and hydrolysis bullet
1-2 parts of albumen of property.
Preferably, skin pigment content is characterized with dermal melanin content MI value, if dermal melanin content MI value >
200, match C1 group functional component；If value≤200 dermal melanin content MI, C2 group functional component is matched；
Preferably, the C1 group component includes: 3-4 parts of Wild soybean albumen, Xylitol-based glucoside 1-3 in parts by weight
Part, 1-3 parts of anhydro xylitol and 1-3 parts of xylitol；
Preferably, the C2 group component includes: 1-3 parts of Wild soybean albumen, Xylitol-based glucoside 1-3 in parts by weight
Part, 1-3 parts of anhydro xylitol and 1-3 parts of xylitol.
Preferably, dermatoglyph degree is characterized with canthus line area, if canthus line area is > 20mm2, match D1 group effect
Ingredient；If 15mm2The canthus < line area≤20mm2, match D2 group functional component；If canthus line area≤15mm2, match D3 group
Functional component；
Preferably, the D1 group component includes: dipeptides diaminobutyryl benzyl amide diacetin 3-5 in parts by weight
Part, 0.5-1 parts of kappaphycus algae extract, 0.5-1 parts of Caesalpinia spinosaKuntze berry extract, 3-5 parts of safflower seed oil, golden button extract 3-
5 parts, 3-5 parts of Astragalus membranacus root extract, 3-5 parts of ubiquinone and 3-5 parts of vitamin E；
Preferably, the D2 group component includes: dipeptides diaminobutyryl benzyl amide diacetin 2-3 in parts by weight
Part, 0.3-0.5 parts of kappaphycus algae extract, 0.3-0.5 parts of Caesalpinia spinosaKuntze berry extract, 2-3 parts of safflower seed oil, golden button extract
2-3 parts of object, 2-3 parts of Astragalus membranacus root extract, 2-3 parts of ubiquinone and 2-3 parts of vitamin E；
Preferably, the D3 group component includes: dipeptides diaminobutyryl benzyl amide diacetin 1-2 in parts by weight
Part, 0.1-0.3 parts of kappaphycus algae extract, 0.1-0.3 parts of Caesalpinia spinosaKuntze berry extract, 1-2 parts of safflower seed oil, golden button extract
1-2 parts of object, 1-2 parts of Astragalus membranacus root extract, 1-2 parts of ubiquinone and 1-2 parts of vitamin E.
Preferably, the eye skin care item are made after the functional component being mixed with matrix components；
Preferably, the matrix components include moisturizer, surfactant, thickener, dispersing agent, antioxidant, flavouring agent,
One or more of emollient, anti-allergic agent, pH adjusting agent, filler, carrier and solvent.
Preferably, in parts by weight, the matrix components include: 1-2 parts of cetostearyl alcohol, 1-2 parts of cocoyl glucoside,
1-3 parts of stearine, 1-3 parts of PEG-100 stearate, 1-3 parts of Sucrose Polystearic Acid Esters, 1-3 parts of Parleam,
1-3 parts of cetanol, 1-3 parts of stearyl alcohol, 2-5 parts of oleyl alcohol eruciate, 2-5 parts of isononyl isononanoate, dimethyl silicone polymer 2-5
Part, 0.2-1 parts of tocopherol acetate, 0.1-0.5 parts of carbomer, 5-10 parts of glycerol, 5-10 parts of dipropylene glycol, 3-5 parts of propylene glycol,
3-5 parts of beta glucan, 0.1-0.5 parts of dipotassium glycyrrhizinate and 0.1-0.5 parts of aminomethyl propanol.
Preferably, the eye skin care item include eye cream, lotion, essence, toner or eye mask.
The present invention also provides a kind of eye maintenance methods, and the method includes using the system of above-mentioned customization eye skin care item
The skin care item that Preparation Method is prepared nurse eye circumference skin.
Compared with prior art, the invention has the following beneficial effects:
The present invention provides a kind of method for customizing of eye skin care item, which includes the characterization according to customized objects
The parameter of eye problems matches functional component, and the eye skin care item comprising the functional component are then made.Due to eye problems
It is closely related with personal hereditary capacity, gender, age, life and working environment and living habit, therefore everyone eye
Problem is all not quite similar, thousand people of existing eye skin care skin, one side, cannot be suitable for the eye problems of different users well.This
Invention uses the eye part skin problem of parameter characterization customized objects, so that the eye part skin problem of customized objects can be more intuitive
Reaction and measurement, then match corresponding functional component according to parameter, and the solution for being directed to the eye skin care item produced more determines
The eye part skin problem of object processed.The inventive concept of method for customizing based on above-mentioned eye skin care item, the present invention also provides one
Kind eye maintenance method, this method include the skin care item nursing being prepared using the preparation method of above-mentioned customization eye skin care item
Eye circumference skin, this method can effectively alleviate eye circumference dry skin problem, restore eye circumference elasticity of skin and reduce wrinkle and
Black eye.
Detailed description of the invention
It, below will be to specific in order to illustrate more clearly of the specific embodiment of the invention or technical solution in the prior art
Embodiment or attached drawing needed to be used in the description of the prior art be briefly described, it should be apparent that, it is described below
Attached drawing is some embodiments of the present invention, for those of ordinary skill in the art, before not making the creative labor
It puts, is also possible to obtain other drawings based on these drawings.
Fig. 1 is that the customization eye cream that the embodiment of the present invention 1 provides is become using canthus test zone moisture content change in 1-8 weeks
Gesture；
Fig. 2 is that the customization eye cream that the embodiment of the present invention 1 provides uses canthus test zone moisture content change in 1-8 weeks
Rate；
Fig. 3 is that the customization eye cream that the embodiment of the present invention 1 provides is changed using eye circumference test zone skin elasticity R2 in 1-8 weeks
Trend；
Fig. 4 is that the customization eye cream that the embodiment of the present invention 1 provides is changed using eye circumference test zone skin elasticity in 1-8 weeks
Rate；
Fig. 5 is that the customization eye cream that the embodiment of the present invention 1 provides uses canthus test zone skin elasticity R2, Q1 in 1-8 weeks
Variation tendency；
Fig. 6 is that the customization eye cream that the embodiment of the present invention 1 provides uses canthus test zone skin elasticity R2, Q1 in 1-8 weeks
Change rate；
Fig. 7 is that the customization eye cream that the embodiment of the present invention 1 provides is changed using eyeground test zone melanin content in 1-8 weeks
Trend；
Fig. 8 is that the customization eye cream that the embodiment of the present invention 1 provides is changed using eyeground test zone melanin content in 1-8 weeks
Rate；
Fig. 9 is that the customization eye cream that the embodiment of the present invention 1 provides uses eye circumference test zone skin smoothness SEsm in 1-8 weeks
It is worth variation tendency；
Figure 10 is that the customization eye cream that the embodiment of the present invention 1 provides uses eye circumference test zone skin smoothness in 1-8 weeks
SEsm value change rate；
Figure 11 is that the customization eye cream that the embodiment of the present invention 1 provides uses canthus line area change trend in 1-8 weeks；
Figure 12 is that the customization eye cream that the embodiment of the present invention 1 provides uses canthus line area change rate in 1-8 weeks；
Figure 13 is that the customization eye cream that the embodiment of the present invention 1 provides uses canthus line test zone Ra, Rt, Rz value in 1-8 weeks
Variation tendency；
Figure 14 is that the customization eye cream that the embodiment of the present invention 1 provides uses canthus line test zone Ra, Rt, Rz value in 1-8 weeks
Change rate；
Figure 15 is that the customization eye cream that the embodiment of the present invention 1 provides uses tear rill area change trend in 1-8 weeks；
Figure 16 is that the customization eye cream that the embodiment of the present invention 1 provides uses tear rill area change rate in 1-8 weeks；
Figure 17 is that the customization eye cream that the embodiment of the present invention 1 provides uses test zone tear rill Ra, Rt, Rz value in 1-8 weeks
Variation tendency；
Figure 18 is that the customization eye cream that the embodiment of the present invention 1 provides uses test zone tear rill Ra, Rt, Rz value in 1-8 weeks
Change rate.
Specific embodiment
Technical solution of the present invention is clearly and completely described below in conjunction with attached drawing, it is clear that described implementation
Example is a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, ordinary skill
Personnel's every other embodiment obtained without making creative work, shall fall within the protection scope of the present invention.
The person that is not specified actual conditions in embodiment, carries out according to conventional conditions or manufacturer's recommended conditions.Agents useful for same or instrument are not
Production firm person is indicated, is the conventional products that can be obtained by commercially available purchase.
In the present invention, if without particularly illustrating, all embodiments mentioned in this article and preferred implementation method
It can be combined with each other to form new technical solution.
In the present invention, if without particularly illustrating, all technical characteristics and preferred feature mentioned in this article can be with
Intercombination forms new technical solution.
In the present invention, if percentage (%) or part refer to the weight relative to composition without particularly illustrating
Percentage or parts by weight.
In the present invention, if related each component or its preferred ingredient can be combined with each other shape without particularly illustrating
The technical solution of Cheng Xin.
In the present invention, unless otherwise indicated, numberical range " a-b " indicates the breviary of any real combinings between a to b
It indicates, wherein a and b is real number.Such as numberical range " 6-22 " expression has all listed between " 6-22 " herein
Whole real numbers, " 6-22 " are that the breviary of these combinations of values indicates.
" range " disclosed in this invention can be respectively one or more lower limits and one in the form of lower and upper limit
A or multiple upper limits.
Unless otherwise indicated, profession used herein and meaning phase known to scientific term and one skilled in the art
Together.In addition, any method similar to or equal to what is recorded or material can also be applied in the present invention.
The present invention provides a kind of method for customizing of eye skin care item, which includes the characterization according to customized objects
The parameter of eye problems matches functional component, and the eye skin care item comprising the functional component are then made.Due to eye problems
It is closely related with personal hereditary capacity, gender, age, life and working environment and living habit, therefore everyone eye
Problem is all not quite similar, existing thousand people of eye skin care item, one side, cannot be suitable for the eye problems of different users well.This
Invention uses the eye part skin problem of parameter characterization customized objects, so that the eye part skin problem of customized objects can be more intuitive
Reaction and measurement, then match corresponding functional component, the solution customized objects for being directed to the eye cream produced more according to parameter
Eye part skin problem.It should be noted that method of the invention is related to skin care field rather than therapeutic treatment field, because
This present invention is not intended to diagnosis or any disease for the treatment of, and is intended to improve user's periocualr skin problem, as black eye, eye pouch,
The problems such as crow's feet.
It is of the present invention characterization eye problems parameter detected optionally from instrument parameter, professional couple
Quantifiable scoring or classification that the assessment of subject's eye problems obtains and for one of questionnaire of subject or
A variety of detect it is preferable to use instrument of person obtains parameter, detected using instrument it is reproducible, and instrument detected value have it is unified
Standard, the scope of application are more extensive.The parameter for the characterization eye problems that instrument detects for example can be but be not limited to moisture
Content, MI value, EI value, fat content, skin elasticity R2 value, skin elasticity R5 value, skin elasticity R7 value, laser-Doppler value,
One or more of wrinkle area and infrared value.
Skin problem is usually embodied in skin elasticity decline, wrinkle increases and deepens, and skin roughness is increased and moistened
The several respects such as degree reduction, eye problems are also especially prominent at above-mentioned several aspects, therefore in some preferred embodiments, institute
Stating eye problems includes one of moisture content of skin, skin pigment content, skin elasticity, dermatoglyph degree and skin smoothness
Or it is a variety of, subject's eye can be directed to using the eye problems for the parameter characterization subject for measuring above-mentioned eye problems to match
The effect of portion's problem ingredient.
It is preferably carried out in mode some, with skin moisture content MMV value characterization moisture content of skin, it is preferable to use skin
Moisture content tester (Corneometer CM 825, Courage and Khazaka, Germany) detection moisture content of skin, should
The probe of tester is that the principle based on capacitor measures.The dielectric constant of water is 81, and the dielectric constant of other substances is usual
Less than 7, water is the maximum substance of dielectric constant on skin.When moisture content changes, the capacitance of skin also becomes
Change, therefore can be by measuring skin pricktest capacitance, the water content on analyzing skin surface.Measured value is a relative value.Unit C.U.
(Corneometer Units) is indicated.
If moisture content of skin be≤40C.U, such as can be but be not limited to 10C.U, 20C.U, 25C.U, 30C.U,
32C.U, 35C.U, 37.5C.U or 40C.U match A1 group functional component；If 40C.U < moisture content of skin≤60C.U, such as can
Think but be not limited to 42C.U, 45C.U, 47.5C.U, 50C.U, 52.5C.U, 55C.U, 58C.U or 60C.U, matches A2 group function
Imitate ingredient；If moisture content of skin > 60C.U, for example, can be but be not limited to 62.5C.U, 65C.U, 68C.U, 70C.U,
73C.U, 75C.U, 77.5C.U, 80C.U or 85C.U match A3 group functional component.
Preferably, A1 group functional component, A2 group functional component and A3 group functional component are independently to include containing slow
The effect of solving moisture content of skin deficiency problem ingredient, ingredient for example can be the effect of the alleviation moisture content of skin deficiency problem
One or more of but be not limited to ceramide, Xylitol-based glucoside, anhydro xylitol, xylitol.
It is preferably carried out in mode some, the A1 group component includes: -5 parts of Cer NP, xylose in parts by weight
5-6 parts of alcohol radical glucoside, 5-6 parts of anhydro xylitol and 5-6 parts of xylitol；Wherein, the parts by weight of ceramide for example can be with
For but be not limited to 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；The parts by weight of Xylitol-based glucoside for example can be but unlimited
In being 5 parts, 5.2 parts, 5.5 parts, 5.8 parts or 6 parts；The parts by weight of anhydro xylitol for example can be but be not limited to 5 parts,
5.2 parts, 5.5 parts, 5.8 parts or 6 parts；The parts by weight of xylitol for example can be but be not limited to 5 parts, 5.2 parts, 5.5 parts,
5.8 parts or 6 parts.
It is preferably carried out in mode some, the A2 group component includes: -3 parts of Cer NS, xylose in parts by weight
3-5 parts of alcohol radical glucoside, 3-5 parts of anhydro xylitol and 3-5 parts of xylitol；Wherein, the parts by weight of ceramide for example can be with
For but be not limited to 2 parts, 2.2 parts, 2.5 parts, 2.7 parts or 3 parts；The parts by weight of Xylitol-based glucoside for example can be but not
It is limited to be 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；The parts by weight of anhydro xylitol for example can be but be not limited to 3 parts,
3.5 parts, 4 parts, 4.5 parts or 5 parts；The parts by weight of xylitol for example can be but be not limited to 3 parts, 3.5 parts, 4 parts, 4.5 parts
Or 5 parts.
It is preferably carried out in mode some, the A3 group component includes: -2 parts of Cer EOS, xylose in parts by weight
1-3 parts of alcohol radical glucoside, 1-3 parts of anhydro xylitol and 1-3 parts of xylitol；Wherein, the parts by weight of ceramide for example can be with
For but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.8 parts or 2 parts；The parts by weight of Xylitol-based glucoside for example can be but not
It is limited to be 1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of anhydro xylitol for example can be but be not limited to 1 part,
1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of xylitol for example can be but be not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts
Or 3 parts.
It is preferably carried out in mode some, detects skin elasticity, test equipment using skin elasticity tester MPA580
It is based on suction and to stretch former for skin elasticity tester (Cutometer dual MPA580, German CK company) test philosophy
Reason generates a negative pressure in one fc-specific test FC probe of skin inspiration in tested skin surface, and skin is sucked into test
Depth in probe is measured by a contactless optic testing system.Test probe in including light transmitter and
The ratio (emitting the ratio between light and reception light) of receiver, light is directly proportional with the depth of skin is inhaled into, and then passes through MPA software point
Analyse the elastic property to determine skin.Coefficient of skin elasticity R2 value, R5 value and R7 value can be obtained using MPA580: R2 is no negative pressure
When skin springback capacity Ua and the ratio between maximum tension amount Uf when having a negative pressure；R5 is skin in the 1st cyclic process of skin test
The elastic part Ur of skin recovery process and the ratio between the elastic part Ue for adding negative pressure process；R7 is that the 1st time of skin test is circulated throughout
The ratio between the maximum tension amount Uf of the elastic part Ur of skin recovery process and skin in current cyclic process in journey.
It is preferred that skin elasticity is characterized with skin elasticity R2 value, if value≤0.5 skin elasticity R2, such as can be but be not limited to
It is 0.1,0.2,0.3,0.4 or 0.5, matches B1 group functional component；If 0.5 value≤0.7 < skin elasticity R2, for example, can be but
It is not limited to 0.5,0.55,0.6,0.65 or 0.7, matches B2 group functional component；If skin elasticity R2 value > 0.7, such as can be with
For but be not limited to 0.7,0.75,0.8,0.85 or 0.9, match B3 group functional component.
Preferably, B1 group functional component, B2 group functional component and B3 group functional component are independently to include containing slow
Solution skin lack flexibility problem the effect of ingredient, the alleviation skin lack flexibility problem the effect of ingredient for example can be but not
It is limited in tetrahydro methylpyrimidine carboxylic acid, safflower seed oil, golden button extract, Astragalus membranacus root extract, ubiquinone and vitamin E
One or more.
It is preferably carried out in mode some, the B1 group component includes: tetrahydro methylpyrimidine carboxylic acid in parts by weight
0.5-1 parts, 3-4 parts of safflower seed oil, golden 3-4 parts of button extract, 3-4 parts of Astragalus membranacus root extract, 3-4 parts of ubiquinone, dimension life
Plain E 3-4 parts and elastin hydrolysis 4-5 parts；Wherein, the parts by weight of tetrahydro methylpyrimidine carboxylic acid for example can be but unlimited
In being 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part or 1 part；The parts by weight of safflower seed oil for example can be but be not limited to
3 parts, 3.2 parts, 3.5 parts, 3.75 parts or 4 parts；The parts by weight of golden button extract for example can be but be not limited to 3 parts, 3.2
Part, 3.5 parts, 3.75 parts or 4 parts；The parts by weight of Astragalus membranacus root extract for example can be but be not limited to 3 parts, 3.2 parts,
3.5 parts, 3.75 parts or 4 parts；The parts by weight of ubiquinone for example can be but be not limited to 3 parts, 3.2 parts, 3.5 parts, 3.75 parts or 4
Part；The parts by weight of vitamin E for example can be but be not limited to 3 parts, 3.2 parts, 3.5 parts, 3.75 parts or 4 parts；Hydrolyzed elastin
The parts by weight of albumen for example can be but be not limited to 4 parts, 4.2 parts, 4.5 parts, 4.75 parts or 5 parts.
It is preferably carried out in mode some, the B2 group component includes: tetrahydro methylpyrimidine carboxylic acid in parts by weight
0.2-0.5 parts, 2-3 parts of safflower seed oil, golden 2-3 parts of button extract, 2-3 parts of Astragalus membranacus root extract, 2-3 parts of ubiquinone, dimension
2-3 parts and elastin hydrolysis 2-4 parts of raw element E.Wherein, the parts by weight of tetrahydro methylpyrimidine carboxylic acid for example can be but not
It is limited to be 0.2 part, 0.25 part, 0.3 part, 0.35 part, 0.4 part, 0.45 part or 0.5 part；The parts by weight of safflower seed oil for example may be used
Think but is not limited to 2 parts, 2.2 parts, 2.5 parts, 2.75 parts or 3 parts；The parts by weight of golden button extract for example can be but
It is not limited to 2 parts, 2.2 parts, 2.5 parts, 2.75 parts or 3 parts；The parts by weight of Astragalus membranacus root extract for example can be but not
It is limited to be 2 parts, 2.2 parts, 2.5 parts, 2.75 parts or 3 parts；The parts by weight of ubiquinone for example can be but be not limited to 2 parts, 2.2
Part, 2.5 parts, 2.75 parts or 3 parts；The parts by weight of vitamin E for example can be but be not limited to 2 parts, 2.2 parts, 2.5 parts,
2.75 parts or 3 parts；The parts by weight of elastin hydrolysis for example can be but be not limited to 2 parts, 2.5 parts, 3 parts, 3.5 parts or 4
Part.
It is preferably carried out in mode some, the B3 group component includes: tetrahydro methylpyrimidine carboxylic acid in parts by weight
0.1-0.2 parts, 1-2 parts of safflower seed oil, golden 1-2 parts of button extract, 1-2 parts of Astragalus membranacus root extract, 1-2 parts of ubiquinone, dimension
1-2 parts and elastin hydrolysis 1-2 parts of raw element E.Wherein, the parts by weight of tetrahydro methylpyrimidine carboxylic acid for example can be but not
It is limited to be 0.1 part, 0.12 part, 0.15 part, 0.18 part or 0.2 part；The parts by weight of safflower seed oil for example can be but be not limited to
It is 1 part, 1.2 parts, 1.5 parts, 1.75 parts or 2 parts；The parts by weight of golden button extract for example can be but be not limited to 1 part,
1.2 parts, 1.5 parts, 1.75 parts or 2 parts；The parts by weight of Astragalus membranacus root extract for example can be but be not limited to 1 part, 1.2
Part, 1.5 parts, 1.75 parts or 2 parts；The parts by weight of ubiquinone for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.75 parts
Or 2 parts；The parts by weight of vitamin E for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.75 parts or 2 parts；Hydrolyze bullet
The parts by weight of property albumen for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.75 parts or 2 parts.
It is preferably carried out in mode some, skin pigment content is characterized with dermal melanin content MI value, if melanin
Index > 200, such as can be but be not limited to 210,220,230,240,250,260,270,280,290 or 300, matching C1
Group functional component；If melanin index≤200, such as can be but be not limited to 150,160,170,180,190 or 200,
With C2 group functional component；
Preferably, C1 group functional component, C2 group functional component and C3 group functional component are independently to include containing subtracting
The effect of few dermal melanin ingredient, ingredient for example can be but be not limited to Wild soybean the effect of the reduction dermal melanin
One or more of albumen, Xylitol-based glucoside, anhydro xylitol and xylitol.
In some preferred embodiments, the C1 group component includes: 3-4 parts of Wild soybean albumen, wood in parts by weight
1-3 parts of sugar alcohol base glucoside, 1-3 parts of anhydro xylitol and 1-3 parts of xylitol.Wherein, the parts by weight of Wild soybean albumen are for example
It can be but be not limited to 3 parts, 3.2 parts, 3.5 parts, 3.75 parts or 4 parts；The parts by weight of Xylitol-based glucoside for example can be with
For but be not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of anhydro xylitol for example can be but be not limited to
1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of xylitol for example can be but be not limited to 1 part, 1.5 parts, 2 parts,
2.5 parts or 3 parts.
In some preferred embodiments, the C2 group component includes: 1-3 parts of Wild soybean albumen, wood in parts by weight
1-3 parts of sugar alcohol base glucoside, 1-3 parts of anhydro xylitol and 1-3 parts of xylitol.Wherein, the parts by weight of Wild soybean albumen are for example
It can be but be not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of Xylitol-based glucoside for example can be but
It is not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of anhydro xylitol for example can be but be not limited to 1 part,
1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of xylitol for example can be but be not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts
Or 3 parts.
In some preferred embodiments, dermatoglyph degree is characterized with canthus line area, if canthus line area is >
20mm2, such as can be but be not limited to 21mm2、22mm2、23mm2、24mm2、25mm2、26mm2、27mm2、28mm2、29mm2
Or 30mm2, match D1 group functional component；If 15mm2The canthus < line area≤20mm2, such as can be but be not limited to 16mm2、
17mm2、18mm2、19mm2Or 20mm2, match D2 group functional component；If canthus line area≤15mm2, such as can be but unlimited
In for 10mm2、11mm2、12mm2、13mm2、14mm2Or 5mm2, match D3 group functional component.
Preferably, D1 group functional component, D2 group functional component and D3 group functional component are independently to include containing slow
The effect of solving canthus line problem ingredient, ingredient for example can be but be not limited to dipeptides two the effect of the alleviation canthus line problem
Aminobutyryl benzyl amide diacetin, kappaphycus algae extract, Caesalpinia spinosaKuntze berry extract, safflower seed oil, golden button extract
Object, Astragalus membranacus root extract and one or more of ubiquinone and vitamin E.
In some preferred embodiments, the D1 group component includes: dipeptides diaminobutyryl benzyl in parts by weight
3-5 parts of amide diacetin, 0.5-1 parts of kappaphycus algae extract, 0.5-1 parts of Caesalpinia spinosaKuntze berry extract, safflower seed oil 3-5
Part, golden 3-5 parts of button extract, 3-5 parts of Astragalus membranacus root extract, 3-5 parts of ubiquinone and 3-5 parts of vitamin E.Wherein, dipeptides
The parts by weight of diaminobutyryl benzyl amide diacetin for example can be but be not limited to 3 parts, 3.5 parts, 4 parts, 4.5 parts or
5 parts；The parts by weight of kappaphycus algae extract for example can be but be not limited to 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9
Part or 1 part；The parts by weight of Caesalpinia spinosaKuntze berry extract for example can be but be not limited to 0.5 part, 0.6 part, 0.7 part, 0.8 part,
0.9 part or 1 part；The parts by weight of safflower seed oil for example can be but be not limited to 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；Gold
The parts by weight of button extract for example can be but be not limited to 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；Astragalus membranacus root mentions
Taking the parts by weight of object for example can be but be not limited to 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；The parts by weight of ubiquinone are for example
It can be but be not limited to 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；The parts by weight of vitamin E for example can be but be not limited to
It is 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts.
In some preferred embodiments, the D2 group component includes: dipeptides diaminobutyryl benzyl in parts by weight
2-3 parts of amide diacetin, 0.3-0.5 parts of kappaphycus algae extract, 0.3-0.5 parts of Caesalpinia spinosaKuntze berry extract, safflower seed oil
2-3 parts, golden 2-3 parts of button extract, 2-3 parts of Astragalus membranacus root extract, 2-3 parts of ubiquinone and 2-3 parts of vitamin E.Wherein,
The parts by weight of dipeptides diaminobutyryl benzyl amide diacetin for example can be but be not limited to 2 parts, 2.2 parts, 2.5 parts,
2.75 parts or 3 parts；The parts by weight of kappaphycus algae extract for example can be but be not limited to 0.3 part, 0.35 part, 0.4 part,
0.45 part or 0.5 part；The parts by weight of Caesalpinia spinosaKuntze berry extract for example can be but be not limited to 0.3 part, 0.35 part, 0.4 part,
0.45 part or 0.5 part；The parts by weight of safflower seed oil for example can be but be not limited to 2 parts, 2.2 parts, 2.5 parts, 2.75 parts or 3
Part；The parts by weight of golden button extract for example can be but be not limited to 2 parts, 2.2 parts, 2.5 parts, 2.75 parts or 3 parts；Film pod
The parts by weight of Radix Astragali root extract for example can be but be not limited to 2 parts, 2.2 parts, 2.5 parts, 2.75 parts or 3 parts；Ubiquinone
Parts by weight for example can be but be not limited to 2 parts, 2.2 parts, 2.5 parts, 2.75 parts or 3 parts；The parts by weight of vitamin E are for example
It can be but be not limited to 2 parts, 2.2 parts, 2.5 parts, 2.75 parts or 3 parts.
In some preferred embodiments, the D3 group component includes: dipeptides diaminobutyryl benzyl in parts by weight
1-2 parts of amide diacetin, 0.1-0.3 parts of kappaphycus algae extract, 0.1-0.3 parts of Caesalpinia spinosaKuntze berry extract, safflower seed oil
1-2 parts, golden 1-2 parts of button extract, 1-2 parts of Astragalus membranacus root extract, 1-2 parts of ubiquinone and 1-2 parts of vitamin E.Wherein,
The parts by weight of dipeptides diaminobutyryl benzyl amide diacetin for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts,
1.75 parts or 2 parts；The parts by weight of kappaphycus algae extract for example can be but be not limited to 0.1 part, 0.15 part, 0.2 part,
0.25 part or 0.3 part；The parts by weight of Caesalpinia spinosaKuntze berry extract for example can be but be not limited to 0.1 part, 0.15 part, 0.2 part,
0.25 part or 0.3 part；The parts by weight of safflower seed oil for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.75 parts or 2
Part；The parts by weight of golden button extract for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.75 parts or 2 parts；Film pod
The parts by weight of Radix Astragali root extract for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.75 parts or 2 parts；Ubiquinone
Parts by weight for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.75 parts or 2 parts；The parts by weight of vitamin E are for example
It can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.75 parts or 2 parts.
It should be noted that A1 group, A2 group, A3 group, B1 group, B2 group, B3 group, C1 group, C2 group, D1 in above embodiment
Group, D2 group and D3 group are only intended to the grouping of corresponding different efficacies ingredient under difference different parameters, are used for description purposes only, and
It cannot be understood as indicating or implying relative importance.
The effect of above-mentioned use, ingredient had the following beneficial effects: that ceramide is the main component of horny layer of epidermis, had
There is maintenance skin barrier, keep moisture of skin, reinforce skin anti-aging function, skin is enabled to keep elasticity, it is smooth careful, reduce face
The effect that portion's wrinkle is formed.Xylitol-based glucoside, anhydro xylitol and xylitol are good moisturizer, can improve skin
Skin moisture content reduces water loss while improving the moisture content of epidermis；Also have and promotes hyaluronic acid and chondroitin sulfate
Cellulose content increases, and promotes ceramide synthesis, and enhancing skin barrier effect has both moisturizing and anti-ageing effect.Tetrahydro methyl is phonetic
Pyridine carboxylic acid is a kind of natural maintenance cell protecting factor, can adjust cell water balance, forms water lock film, lock in skin surface
Firmly skin moisture maintains skin humidity, softness and smoothness, and also there is protection cell and enhancing cell resistance UV light temperature to make
With.Safflower seed oil is that have using the seed of safflower (CARTHAMUS TINCTORIUS) as the oil product of waste and promote skin new
City metabolism, promotes skin to restore effect of elasticity；Safflower seed oil or a kind of natural, it to human body cell divide,
Anti-aging important role；Safflower seed oil is suitble to various skin quality, has pore refining, and dry skin is alleviated in skin whitening,
The effect of repairing the skin and delay skin aging of sunburn.Golden button (SPILANTHES ACMELLA) be composite family, Spilanthes,
Quasi- Spilanthes oleracea kind plant, gold button extract of the present invention are at least one of golden bachelor's button, leaf and extract of stem,
The isobutylamides and great active spilanthol that golden button extract is rich in, by the biomethanics function for intensifying fibrocyte
Can, to reform the structure of corium, promote the density of skin and the degree of packing rapidly, reduces the roughness of skin, smooth skin
Activity, can quickly reduce canthus fishtail line, there is effective crease-resistant effect, can effectively inhibit tyrosinase activity and black
The synthesis of element achievees the effect that improve skin pigmentation and skin whitening.Astragalus membranacus (ASTRAGALUS
MEMBRANACEUS) root extract is containing the lot of trace member such as saponin, sucrose, polysaccharide, a variety of amino acid, folic acid and selenium, zinc, copper
Element: the physiological metabolism of cell can be made to act on enhancing, stimulate the proliferation of Skin Cell, there is conditioning skin and wrinkle resistant anti-ageing work
With.Ubiquinone, also known as ubiquinone (CoQ), for a kind of fat-soluble quinones, ubiquinone has crease-resistant effect, has anti-oxidant, clear
Except free radical, stablize the effects of biomembrane.Vitamin E: can effectively clear oxygen radical, and anti-lipid peroxidation can effectively subtract
The formation of few pigment deposition and color spot has wrinkle resistant, water lock, promotes absorption and anti-wrinkle effect.Elastin hydrolysis: elastic egg
White is the main component of elastomer in rawhide tissue, and elastin laminin plays the part of the role of rubber band in skin, allows skin to have and stretches
The ability of exhibition and flatung.Elastin laminin molecular weight after hydrolysis is smaller, skin can be promoted adequately to absorb, and increases skin collagen egg
White and elastin laminin content, significantly improves skin inner tensions and elastic force, reinforces the collagen activity of skin, keeps cutin
Moisture, improvement from inside to outside simultaneously reduce wrinkle, improve compact sense, increase the effect of skin elasticity is to delay senescence.It is wild big
Legumin has nti-freckle and oxidation resistant effect with that can significantly reduce melanin, bright color.Dipeptides diaminobutyryl benzyl
Base amide diacetin is small molecule tripeptides, and activity has been imitated the activity of protein Waglerin-1 in the Pallas pit viper venom of mausoleum, can have been hindered
Neurotransmission on disconnected acetylcholinergic receptor, to loosen pseudo wrinkle.It can imitate to anti-wrinkle, especially Eradicates except expression
Line, smooth wrinkle, facial muscles are loosened in help, while not influencing facial expression.Kappaphycus alvarezi (KAPPAPHYCUS
ALVAREZII) extract is under the jurisdiction of Rhodophyta, Rhodophyceae, Gigartinales, solieria section, Kappa Trentepohlia, and extract contains abundant
Galactan sulfate, can smooth face and body immediately skin nan orelief, quickly and persistently desalinate wrinkle, reach immediately flat
The effect of sliding firm skin has effects that extend the skin service life and delays its naturally-aged process；It can also melanin processed
It generates, and has the function of anti-oxidant and moisturizing whitening.Caesalpinia spinosaKuntze (CAESALPINIA SPINOSA) berry extract contains abundant
Galactomannans, flexible and non-blocking film can be formed in skin surface, there is compact lifting skin and instant crease-resistant
Effect.Also, on the basis of the effect of effect ingredient in above-mentioned each group component respectively, by reasonable in present embodiment
The dosage of effect ingredient and reasonably combined each component in selection each group component, which makes it also, has the function of synergy；Simultaneously
In the present embodiment the collocation also according to the Rational Parameters of subject's eye problems and pick functional component and effect at
The dosage divided is so that the eye skin care item after collocation can more effectively solve the eye problems of subject.By adjusting and optimization
The selection of ingredient in each group component and the proportion of dosage can advanced optimize the using effect of customization eye skin care item.
In some alternative embodiments, the eye skin care is made after the functional component being mixed with matrix components
Product, the production method of eye skin care item of the present invention, may be selected existing routine techniques in manufacture craft, such as plus
Heat, stirring and homogeneous etc., the present invention to production method with no restrictions.
In some preferred embodiments, the matrix components include moisturizer, surfactant, thickener, dispersion
One or more of agent, antioxidant, flavouring agent, emollient, anti-allergic agent, pH adjusting agent, filler, carrier and solvent.?
In some preferred embodiments, in parts by weight, the matrix components include: 1-2 parts of cetostearyl alcohol, cocoyl glucoside
1-2 parts, 1-3 parts of stearine, 1-3 parts of PEG-100 stearate, 1-3 parts of Sucrose Polystearic Acid Esters, Parleam
1-3 parts, 1-3 parts of cetanol, 1-3 parts of stearyl alcohol, 2-5 parts of oleyl alcohol eruciate, 2-5 parts of isononyl isononanoate, polydimethylsiloxanes
2-5 parts of alkane, 0.2-1 parts of tocopherol acetate, 0.1-0.5 parts of carbomer, 5-10 parts of glycerol, 5-10 parts of dipropylene glycol, propylene glycol
3-5 parts, 3-5 parts of beta glucan, 0.1-0.5 parts of dipotassium glycyrrhizinate and 0.1-0.5 parts of aminomethyl propanol.
Wherein, the parts by weight of cetostearyl alcohol for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.8 parts or 2
Part；The parts by weight of cocoyl glucoside for example can be but be not limited to 1 part, 1.2 parts, 1.5 parts, 1.8 parts or 2 parts；Glycerol
The parts by weight of stearate for example can be but be not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；PEG-100 stearic acid
The parts by weight of ester for example can be but be not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；The weight of Sucrose Polystearic Acid Esters
Number for example can be but be not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of Parleam for example may be used
Think but is not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of cetanol for example can be but be not limited to 1
Part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；The parts by weight of stearyl alcohol for example can be but be not limited to 1 part, 1.5 parts, 2 parts, 2.5
Part or 3 parts；The parts by weight that 1-3 parts of stearyl alcohol for example can be but be not limited to 1 part, 1.5 parts, 2 parts, 2.5 parts or 3 parts；Oil
The parts by weight of alcohol eruciate for example can be but be not limited to 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；Different nonyl
The parts by weight of the different nonyl ester of acid for example can be but be not limited to 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；Poly- two
The parts by weight of methylsiloxane for example can be but be not limited to 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；It is raw
Educate phenol acetic acid esters parts by weight for example can be but be not limited to 0.2 part, 0.3 part, 0.4 part, 0.5 part, 0.6 part, 0.7 part,
0.8 part, 0.9 part or 1 part；The parts by weight of carbomer for example can be but be not limited to 0.1 part, 0.2 part, 0.3 part, 0.4 part
With 0.5 part；The parts by weight of glycerol for example can be but be not limited to 5 parts, 6 parts, 7 parts, 8 parts, 9 parts or 10 parts；Dipropylene glycol
Parts by weight for example can be but be not limited to 5 parts, 6 parts, 7 parts, 8 parts, 9 parts or 10 parts；The parts by weight of propylene glycol are for example
It can be but be not limited to 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；The parts by weight of beta glucan for example can be but be not limited to
It is 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts；The parts by weight of dipotassium glycyrrhizinate for example can be but be not limited to 0.1 part, 0.2
Part, 0.3 part, 0.4 part and 0.5 part；The parts by weight of aminomethyl propanol for example can be but be not limited to 0.1 part, 0.2 part, 0.3
Part, 0.4 part and 0.5 part.By adjusting the selection and proportion of matrix components, the dosage form and enhancing skin of eye skin care item can adjust
Absorption to wherein functional component.
In some alternative embodiments, can according to specify multinomial use habit and eye problems by eye skin care
Eye cream, lotion, essence, toner or eye mask is made in product, to adapt to the demand of different crowd.
The present invention also provides a kind of eye maintenance method, this method is included in eye circumference and smears using above-mentioned customization eye shield
The skin care item that the preparation method of skin product is prepared.The preparation method base of the eye maintenance method and above-mentioned customization eye skin care item
In identical inventive concept, all beneficial effects of the preparation method with above-mentioned customization eye skin care item, details are not described herein.
Beneficial effects of the present invention are further illustrated below with reference to preferred embodiment.
The test method that the parameter of eye part skin problem is respectively characterized in embodiment and comparative example is as follows:
Skin moisture content MMV value uses skin moisture content tester (Corneometer CM 825, Courage
And Khazaka, Germany) measurement；Skin elasticity uses skin elasticity tester (Cutometer dual MPA580, German CK
Company) measurement.
Pigment content, skin shine, skin elasticity and the skin smoothness of periocualr skin use VISIA skin detection instrument
Detection, to avoid the accuracy for influencing to test, it is necessary to after keeping skin of face noresidue dressing, sit quietly in constant-temperature constant-humidity environment
20-30min makes skin be restored to normal physiological status.Broken hair is cleared up, headgear is taken, prevents broken hair from influencing detection data.?
It in constant-temperature constant-humidity environment, after user head is fixed, takes pictures to the positive face of the user, analyzes eye part skin situation.It uses
The ultra high-definition camera of detecting instrument VISIA, by white light, polarised light, ultraviolet light imaging, by the spot of eye part skin, wrinkle,
The problems such as color spot, skin turgor, veins beneath the skin, is presented, thus obtain the skin pigment content of periocualr skin, skin shine,
Skin elasticity, skin smoothness.
Skin pigment content: the principle (RGB) based on spectral absorption, by measuring the illumination of specific wavelength in human skin
Volume reflection after upper determines the content of melanin and ferroheme in skin.Dermal melanin content MI value measurement numerical value is higher,
Illustrate that melanin content is higher in skin.Skin content of hemachrome EI measurement numerical value is higher, illustrates blood red pigment content in skin
It is higher.Unit: dimensionless.
Dermatoglyph degree: skin instant imaging analysis system Derma TOP uses fringe projection measuring technique (Fringe
Projection the wrinkle of skin) is detected.It is a kind of non-contacting method for fast measuring, and it is rapid-result fastly to can be carried out three-dimensional cutaneous
Picture completes measurement using blue-light source in one second.VISIOFACE V4 by head sensor, two ear sensors and
Facial laser positioning function makes Derma TOP system have the secondary positioning function of extraordinary face.Unit: mm.
Ra value is arithmetic average roughness, refers on purported skin straight line grey scale curve to the range averaging of average gray value
Value.I.e. within the scope of straight length, the arithmetic of absolute value of each point to profile middle line distance is flat on tested skin surface contours line
Mean value.
Rt value skin roughness, in all sections of skin, between gray scale peak value maximum on straight line and minimal gray peak value
Difference.The parameter is the maximum height of skin surface unevenness, i.e., top is to the height between lowest trough in measuring section.
Rz value skin mean roughness, in the arithmetic equal value of the baseline upper and lower skin mound profile of purported skin, i.e., in the limit
In section, it is divided into 5 equal parts by the limitation of length, finds out every section first with skin mound under skin mound profile (maximum gradation value) on baseline and baseline
Difference between profile (minimum gradation value), i.e. skin roughness ask the roughness average in the length baseline (to calculate again later
Art average value) it is skin mean roughness.This parameter and the number of wrinkle of skin are how many, thickness, the depth have close relationship.
Image analysis: application face image analysis system VISIA-CR carries out Image Acquisition to subject, at image
Reason enhancing analysis system Image-Plus Chinese Version 7.0.1 draws in face-image and takes equivalent surface area
Carry out correlation analysis.
Skin smoothness: test equipment is skin microscope and viable skin surface analysis system (VisioScan
VC98USB, German CK company), test equipment is tested by the skin image CCD with ultraviolet source in a special probe
System is tested in skin surface, can be obtained by the activated state image of skin in this way.This black-and-white video signal is inputted
It is handled, then is input in computer into the digitizer of test macro, it is soft by dedicated viable skin surface assessment
Part SELS, which carries out analysis, can be obtained by the numerical parameter of evaluation viable skin surface appearance.SEsm value characterizes smoothness, more flat
Sliding skin is narrower on the histogram picture traverse of intensity profile, and numerical value is smaller.
Embodiment 1
Moisture content of skin, skin elasticity R2 value, melanin content MI value and the canthus line area of test subject, is tied
Fruit is as follows:
Moisture content of skin: 59.63C.U；Periocualr skin elasticity R2 value: 0.5328；Canthus skin elasticity R2 value: 0.5995；It is black
Pigment content MI value: 202.87；Canthus line area: 24.94mm2；
The effect of obtaining formula composition proportion is as follows: .5 parts of Cer NS, 6 parts of Xylitol-based glucoside, anhydro xylitol
6 parts, 6 parts of xylitol, 0.5 part of tetrahydro methylpyrimidine carboxylic acid, 5 parts of safflower seed oil, golden 5 parts of button extract, Astragalus membranacus root mention
Take 5 parts of object, 3 parts of ubiquinone, 3 parts of vitamin E, 3 parts of elastin hydrolysis, 3.5 parts of Wild soybean albumen, dipeptides diaminobutyryl benzyl
4 parts of base amide diacetin, 0.8 part of kappaphycus algae extract, 0.8 part of Caesalpinia spinosaKuntze berry extract；
Matrix components are as follows: 1.5 parts of cetostearyl alcohol, 1.5 parts of cocoyl glucoside, 2 parts of stearine, PEG-
100 2 parts of stearates, 2 parts of Sucrose Polystearic Acid Esters, 2 parts of Parleam, 2 parts of cetanol, 2 parts of stearyl alcohol, oleyl alcohol erucic acid
4 parts of ester, 4 parts of isononyl isononanoate, 3.5 parts of dimethyl silicone polymer, 1 part of tocopherol acetate, 0.5 part of carbomer, glycerol 10
Part, 8 parts of dipropylene glycol, 4 parts of propylene glycol, 4 parts of beta glucan, 0.4 part of dipotassium glycyrrhizinate and 0.4 part of aminomethyl propanol.
Above-mentioned functional component and matrix components are made to customization eye cream after mixing.Application method: it after morning and evening clean skin, takes
Soya bean size is applied to eye circumference, is massaged into absorption.Subject pays a return visit the time: the 0th week, the 1st week, the 2nd week, the 4th week, the 8th week.
Effect example 1 improves canthus skin moisture content effect
Test method:
Skin moisture content MMV value, value is bigger, and moisture content is bigger, conversely, moisture content is smaller.Hydration rate becomes
Rate, this value is higher, and moisturizing effect is more obvious.
The results are shown in Table 1 for skin moisture content MMV Data-Statistics；Subject's test area skin moisture changes of contents trend
And change rate is as depicted in figs. 1 and 2, wherein * indicates p < 0.05, i.e., there were significant differences with the 0th week.It can be with by table 1, Fig. 1 and Fig. 2
Find out, within 8 weeks test periods, after subject uses test sample, canthus test area skin moisture content is used with sample
Time gradually rises, and is above at the 1st week, the 2nd week, the 4th week and the 8th week before use, and there are significant difference (p < 0.05)；
Canthus test zone skin hydration rate was positive value at the 1st week, the 2nd week, the 4th week and the 8th week, and was increased with sample using the time
Add and increase, reaches 26.01% in the 8th week canthus improvement rate；Described above, test sample can significantly improve canthus region skin
Skin moisture content, and using having positive effect (p < 0.05) after sample 1 week, be used continuously 8 weeks lasts significantly (p <
0.05)。
The statistical result of 1 skin moisture content MMV value of table
| Skin moisture content | 0th week | 1st week | 2nd week | 4th week | 8th week |
| Mean value | 59.63 | 68.56 | 69.55 | 70.50 | 74.05 |
| SD value | 8.77 | 8.93 | 8.01 | 7.07 | 7.17 |
| △ difference | / | 8.93 | 9.92 | 10.87 | 14.42 |
| Change rate (%) | / | 16.25 | 17.87 | 19.84 | 26.01 |
| Significance analysis | / | p<0.05 | p<0.05 | p<0.05 | p<0.05 |
Note: it is replaced by vacancy with "/" in table
Effect example 2 improves periocualr skin elasticity
For skin elasticity R2 value closer to 1, skin elasticity is better；The change rate of R2 value is higher, and sample improves skin elasticity
Effect is better.The results are shown in Table 2 for subjects skin elasticity R2 Data-Statistics；Subject is surveyed using eye circumference after customization eye cream 1-8 weeks
Try area skin elasticity R2 variation tendency and skin elasticity change rate result it is as shown in Figure 3 and Figure 4, wherein wherein * indicate p <
0.05, i.e., there were significant differences with the 0th week.It can be seen from table 2, Fig. 3 and Fig. 4 within 8 weeks test periods, subject uses survey
After test agent, eye circumference test zone skin elasticity R2 value is gradually risen with sample using the time, hence it is evident that is higher than before use, and existing
Significant difference (p < 0.05)；The change rate of eye circumference test zone skin elasticity R2 value was at the 1st week, the 2nd week, the 4th week and the 8th week
Shi Junwei positive value reaches 25.59% in the 8th week eye circumference improvement rate；Described above, test sample can significantly improve periocular area
Skin elasticity, and using having positive effect (p < 0.05) after sample 1 week, it is significant (p < 0.05) that 8 weeks lasts are used continuously.
The statistical result of 2 periocualr skin elasticity R2 of table
| R2 value | 0th week | 1st week | 2nd week | 4th week | 8th week |
| Mean value ± SD value | 0.5328 | 0.5841 | 0.5713 | 0.5930 | 0.6572 |
| SD value | 0.0740 | 0.0600 | 0.0554 | 0.0601 | 0.0693 |
| △ difference | / | 0.0513 | 0.0385 | 0.0602 | 0.1244 |
| Change rate (%) | / | 11.40 | 9.05 | 13.47 | 25.59 |
| Significance analysis | / | p<0.05 | p<0.05 | p<0.05 | p<0.05 |
Note: it is replaced by vacancy with "/" in table
Effect example 3 improves canthus skin elasticity
For skin elasticity R2 value closer to 1, skin elasticity is better；The change rate of R2 value is higher, and sample improves skin elasticity
Effect is better；For skin elasticity Q1 value closer to 1, skin elasticity is better；The change rate of Q1 value is higher, and sample improves skin elasticity
Effect is better.Subject is as shown in table 3 using the statistical result of customization 1-8 weeks canthus coefficient of skin elasticity of eye cream, canthus test
Area skin elasticity R2, Q1 variation tendency and change rate are as shown in Figure 5 and Figure 6, wherein * indicate p < 0.05, i.e., with the 0th Zhou Youxian
Write difference.It can be seen from table 3, Fig. 5 and Fig. 6 within 8 weeks test periods, after subject uses test sample, canthus test section
Domain skin elasticity Q1 value, R2 value are gradually risen with sample using the time, hence it is evident that higher than before use, and there are significant difference (p <
0.05)；Canthus test zone skin elasticity Q1 value, R2 value change rate be positive the 1st week, the 2nd week, the 4th week and the 8th Zhou Shijun
Value, and increased with sample using the time and increased, reach 17.09%, Q1 value improvement rate in the 8th week canthus R2 value improvement rate and reaches
21.11%；Described above, test sample can significantly improve canthus area skin elasticity, and obvious using having after sample 2 weeks
It is significant (p < 0.05) that 8 weeks lasts are used continuously in effect (p < 0.05).
The statistical result of 3 canthus coefficient of skin elasticity of table
Note: it is replaced by vacancy with "/" in table
4 Vitamin K effect of effect example
MI value is dermal melanin content, and EI value is skin content of hemachrome, and numerical value is bigger, and pigment content is higher；MI value,
EI value change rate, this value is lower, and sample reduces eyeground dermal melanin and the effect of ferroheme is better, Vitamin K effect
It is more obvious.Subject is as shown in table 4 using eyeground test zone melanin content statistical result in customization eye cream 1-8 weeks, eyeground
Test zone melanin content variation tendency and change rate are as shown in Figure 7 and Figure 8, and wherein * indicates p < 0.05, i.e., had with the 0th week
Significant difference.It can be seen from table 4, Fig. 7 and Fig. 8 within 8 weeks test periods, after subject uses test sample, eyeground test
Area skin melanin content MI value and content of hemachrome EI value are gradually decreased with sample using the time, hence it is evident that lower than use
Before, and there are significant difference (p < 0.05)；The change rate of MI value and EI value was in the 1st week, the 2nd week, the 4th week and the 8th Zhou Shijun
For negative value, and increased with sample using the time and reduced, it is (absolute to reach 15.92% in the 8th week eyeground dermal melanin improvement rate
Value), skin ferroheme improvement rate reaches 4.69% (absolute value)；It is described above, test sample reduce eyeground dermal melanin and
Content of hemachrome, the effect of Vitamin K are obvious (p < 0.05).
4 eyeground test zone melanin content statistical result of table
Note: it is replaced by vacancy with "/" in table
The smooth skin effect of effect example 5
SEsm value characterizes smoothness, and more smooth skin is narrower on the histogram picture traverse of intensity profile, and numerical value is smaller.
SEsm value change rate is lower, and the smooth skin effect of test sample is better.Subject is flat using periocualr skin in customization eye cream 1-8 weeks
The results are shown in Table 5 for slippery SEsm Data-Statistics, eye circumference test zone skin smoothness SEsm value variation tendency and change rate such as Fig. 9
With shown in Figure 10, wherein * indicates p < 0.05, i.e., there were significant differences with the 0th week.It is being tested it can be seen from table 5, Fig. 9 and Figure 10
In 8 weeks periods, after subject uses test sample, eye circumference test zone skin smoothness SEsm value was the 1st week, the 2nd week, the 4th
Lower than before use, and there are significant difference (p < 0.05) at the 4th week and the 8th week when week and the 8th week；Skin smoothness SEsm value
Change rate be negative value at the 1st week, the 2nd week, the 4th week and the 8th week, in changing for the 8th week periocualr skin smoothness SEsm value
Kind rate reaches 8.00% (absolute value)；Described above, the effect of the smooth skin of test sample is obvious, and is using after sample 4 weeks
Have positive effect (p < 0.05), it is significant (p < 0.05) that 8 weeks lasts are used continuously.
5 periocualr skin smoothness SEsm Data-Statistics result of table
| Skin smoothness | 0th week | 1st week | 2nd week | 4th week | 8th week |
| Mean value ± SD value | 150.73±42.99 | 144.06±39.68 | 137.95±38.68 | 135.67±37.23 | 134.69±30.11 |
| △ difference | / | -6.67 | -12.78 | -15.06 | -16.04 |
| Change rate (%) | / | -2.79 | -6.17 | -7.76 | -8.00 |
| Significance analysis | / | p>0.05 | p>0.05 | p<0.05 | p<0.05 |
Note: it is replaced by vacancy with "/" in table
Effect example 6 desalinates canthus line effect
VISIA-CR analyzes result: canthus line area, numerical value is lower, illustrates that selected areas inner eye corner line area is smaller, eye
The change rate of angle line area is lower, and it is better that sample desalinates canthus line effect.Subject uses canthus line face in customization eye cream 1-8 weeks
Product statistical result it is as shown in table 6, canthus line area change trend and change rate as is illustrated by figs. 11 and 12, wherein * indicate p <
0.05, i.e., there were significant differences with the 0th week.It can be seen from table 6, Figure 11 and Figure 12 within 8 weeks test periods, subject is used
After test sample, canthus line area is at the 1st week, the 2nd week, the 4th week and the 8th week lower than before use, and the 4th week and the 8th week
There are significant difference (p < 0.05)；The change rate of canthus line area was negative the 1st week, the 2nd week, the 4th week and the 8th Zhou Shijun
Value, reaches 10.35% (absolute value) in the improvement rate of the 8th week eye circumference canthus line area；Described above, test sample desalinates canthus
The effect of line is obvious, and using having positive effect (p < 0.05) after sample 4 weeks, be used continuously 8 weeks lasts significantly (p <
0.05)。
6 canthus line area statistics result of table
| Tear rill area | 0th week | 1st week | 2nd week | 4th week | 8th week |
| Mean value ± SD value | 24.94±12.09 | 23.93±11.77 | 23.28±11.61 | 21.61±10.12 | 20.92±9.88 |
| △ difference | / | -1.01 | -1.66 | -3.33 | -4.02 |
| Change rate (%) | / | -2.63 | -7.33 | -12.89 | -12.45 |
| Significance analysis | / | p>0.05 | p<0.05 | p<0.05 | p<0.05 |
Note: it is replaced by vacancy with "/" in table
Derma TOP analyzes result: Ra value is arithmetic average roughness, and Rt value is skin roughness, and Rz value is flat for skin
Equal roughness, numerical value is lower, and dermatoglyph degree is lower, and change rate is lower, and it is better that sample improves wrinkle of skin effect.Subject makes
It the results are shown in Table as shown in table 7 with canthus line test zone Ra, Rt, Rz Data-Statistics in customization eye cream 1-8 weeks, canthus line test zone
Ra, Rt, Rz value variation tendency and change rate are as shown in Figure 13 and Figure 14, and wherein * indicates p < 0.05, i.e., had significance difference with the 0th week
It is different.It can be seen from table 7, Figure 13 and Figure 14 within 8 weeks test periods, after subject uses test sample, canthus line Ra, Rt,
Rz value at the 1st week, the 2nd week, the 4th week and the 8th week be lower than before use, and the 4th week and the 8th week there are significant difference (p <
0.05)；The change rate of canthus line Ra, Rt, Rz value was negative value at the 1st week, the 2nd week, the 4th week and the 8th week, in the 8th week eye
The improvement rate of angle line Ra value, Rt value and Rz value is respectively 9.90%, 7.87% and 8.72% (absolute value)；It is described above, test
The effect that sample desalinates canthus line is obvious, and using having positive effect (p < 0.05) after sample 4 weeks, 8 weeks effects are used continuously
Continue significant (p < 0.05).
7 canthus line test zone Ra, Rt, Rz Data-Statistics result of table
Note: it is replaced by vacancy with "/" in table
Effect example 7 desalinates tear rill
VISIA-CR analyzes result: tear rill area, numerical value is lower, illustrates that tear rill area is smaller in selected areas, tear
The change rate of rill area is lower, and it is better that sample desalinates tear rill effect.Subject uses tear rill face in customization eye cream 1-8 weeks
Product statistical result it is as shown in table 8, tear rill area change trend and change rate are as shown in Figure 15 and Figure 16, wherein * indicate p <
0.05, i.e., there were significant differences with the 0th week.It can be seen from table 8, Figure 15 and Figure 16 within 8 weeks test periods, subject is used
After test sample, tear rill area at the 1st week, the 2nd week, the 4th week and the 8th week be lower than before use, and at the 2nd week, the 4th week and
There are significant difference (p < 0.05) within 8th week；The change rate of tear rill area was the 1st week, the 2nd week, the 4th week and the 8th Zhou Shijun
For negative value, reach 12.45% (absolute value) in the improvement rate of the 8th week eye circumference tear rill area；It is described above, test sample desalination
The effect of tear rill is obvious, and using having positive effect (p < 0.05) after sample 4 weeks, 8 weeks lasts of continuous use are significant
(p<0.05)。
8 tear rill area statistics result of table
| Tear rill area | 0th week | 1st week | 2nd week | 4th week | 8th week |
| Mean value ± SD value | 24.94±12.09 | 23.93±11.77 | 23.28±11.61 | 21.61±10.12 | 20.92±9.88 |
| △ difference | / | -1.01 | -1.66 | -3.33 | -4.02 |
| Change rate (%) | / | -2.63 | -7.33 | -12.89 | -12.45 |
| Significance analysis | / | p>0.05 | p<0.05 | p<0.05 | p<0.05 |
Note: it is replaced by vacancy with "/" in table
Derma TOP analyzes result: Ra value is arithmetic average roughness, and Rt value is skin roughness, and Rz value is flat for skin
Equal roughness, numerical value is lower, and dermatoglyph degree is lower, and change rate is lower, and it is better that sample improves wrinkle of skin effect.Subject makes
It the results are shown in Table as shown in table 9 with tear rill test zone Ra, Rt, Rz Data-Statistics in customization eye cream 1-8 weeks, tear rill test zone
Ra, Rt, Rz value variation tendency and change rate are as shown in Figure 17 and Figure 18, and wherein * indicates p < 0.05, i.e., had significance difference with the 0th week
It is different.It can be seen from table 9, Figure 17 and Figure 18 within 8 weeks test periods, after subject uses test sample, tear rill Ra, Rt,
Rz value was lower than at the 1st week, the 2nd week, the 4th week and the 8th week before use, and that at the 2nd week, the 4th week and the 8th week, there are conspicuousnesses was poor
Different (p < 0.05)；The change rate of tear rill Ra, Rt, Rz value was negative value at the 1st week, the 2nd week, the 4th week and the 8th week, the 8th
The improvement rate of all tear rill Ra values, Rt value and Rz value is respectively 13.06%, 14.50% and 12.69% (absolute value)；It says above
Bright, the effect that test sample desalinates tear rill is obvious, and using having positive effect (p < 0.05) after sample 2 weeks, is used continuously 8
All lasts are significant (p < 0.05).
9 tear rill test zone Ra, Rt, Rz Data-Statistics result of table
Note: it is replaced by vacancy with "/" in table
Embodiment 2
Moisture content of skin, skin elasticity R2 value, melanin content MI value and the canthus line area of test subject, is tied
Fruit is as follows:
Moisture content of skin: 75.45C.U；Periocualr skin elasticity R2 value: 0.7664；Canthus skin elasticity R2 value: 0.7784；It is black
Pigment content MI value: 236.45；Canthus line area: 11.84mm2；
The effect of obtaining formula composition proportion is as follows: Cer EOS part, 3 parts of Xylitol-based glucoside, anhydro xylitol 3
Part, 3 parts of xylitol, 0.1 part of tetrahydro methylpyrimidine carboxylic acid, 1 part of safflower seed oil, golden 1 part of button extract, Astragalus membranacus root extract
1 part of object, 1 part of ubiquinone, 1 part of vitamin E, 1 part of elastin hydrolysis, 4 parts of Wild soybean albumen, dipeptides diaminobutyryl benzyl acyl
1 part of amine diacetin, 0.15 part of kappaphycus algae extract, 0.15 part of Caesalpinia spinosaKuntze berry extract；
Matrix components are as follows: 1 part of cetostearyl alcohol, 1 part of cocoyl glucoside, 1 part of stearine, PEG-100 are hard
1 part of resin acid ester, 1 part of Sucrose Polystearic Acid Esters, 1 part of Parleam, 1 part of cetanol, 1 part of stearyl alcohol, oleyl alcohol eruciate 2
It is part, 2 parts of isononyl isononanoate, 2 parts of dimethyl silicone polymer, 0.2 part of tocopherol acetate, 0.1 part of carbomer, 5 parts of glycerol, double
Third 5 parts of glycol, 3 parts of propylene glycol, 3 parts of beta glucan, 0.1 part of dipotassium glycyrrhizinate and 0.1 part of aminomethyl propanol.
Above-mentioned functional component and matrix components are made to customization eye cream after mixing.
Embodiment 3
Moisture content of skin, skin elasticity R2 value, melanin content MI value and the canthus line area of test subject's second, obtain
As a result as follows:
Moisture content of skin: 45.59C.U；Periocualr skin elasticity R2 value: 0.5785；Canthus skin elasticity R2 value: 0.5687；It is black
Pigment content MI value: 180.58；Canthus line area: 14.58mm2；
The effect of obtaining formula composition proportion is as follows: 4 parts of ceramide, 6 parts of Xylitol-based glucoside, anhydro xylitol 6
Part, 6 parts of xylitol, 0.5 part of tetrahydro methylpyrimidine carboxylic acid, 4 parts of safflower seed oil, golden 5 parts of button extract, Astragalus membranacus root extract
5 parts of object, 5 parts of ubiquinone, 5 parts of vitamin E, 3 parts of elastin hydrolysis, 2 parts of Wild soybean albumen, dipeptides diaminobutyryl benzyl acyl
2 parts of amine diacetin, 0.3 part of kappaphycus algae extract, 0.3 part of Caesalpinia spinosaKuntze berry extract；
Matrix components are as follows: 1 part of cetostearyl alcohol, 2 parts of cocoyl glucoside, 1 part of stearine, PEG-100 are hard
3 parts of resin acid ester, 1 part of Sucrose Polystearic Acid Esters, 3 parts of Parleam, 1 part of cetanol, 3 parts of stearyl alcohol, oleyl alcohol eruciate 2
It is part, 5 parts of isononyl isononanoate, 2 parts of dimethyl silicone polymer, 1 part of tocopherol acetate, 0.1 part of carbomer, 10 parts of glycerol, double
Third 5 parts of glycol, 5 parts of propylene glycol, 3 parts of beta glucan, 0.5 part of dipotassium glycyrrhizinate and 0.1 part of aminomethyl propanol.
Above-mentioned functional component and matrix components are made to customization eye cream after mixing,
Embodiment 4
Moisture content of skin, skin elasticity R2 value, melanin content MI value and the canthus line area of test subject third, obtains
As a result as follows:
Moisture content of skin: 35.89C.U；Periocualr skin elasticity R2 value: 0.3582；Canthus skin elasticity R2 value: 0.3416；It is black
Pigment content MI value: 170.56；Canthus line area: 28.63mm2；
The effect of obtaining formula composition proportion is as follows: 5 parts of ceramide, 8 parts of Xylitol-based glucoside, anhydro xylitol 8
Part, 8 parts of xylitol, 1 part of tetrahydro methylpyrimidine carboxylic acid, 9 parts of safflower seed oil, golden 9 parts of button extract, Astragalus membranacus root extract
9 parts, CoQ9 part, 9 parts of vitamin E, 5 parts of elastin hydrolysis, 1.5 parts of Wild soybean albumen, dipeptides diaminobutyryl benzyl acyl
5 parts of amine diacetin, 1 part of kappaphycus algae extract and 1 part of Caesalpinia spinosaKuntze berry extract；
Matrix components are as follows: 2 parts of cetostearyl alcohol, 1 part of cocoyl glucoside, 3 parts of stearine, PEG-100 are hard
1 part of resin acid ester, 3 parts of Sucrose Polystearic Acid Esters, 1 part of Parleam, 3 parts of cetanol, 1 part of stearyl alcohol, oleyl alcohol eruciate 5
It is part, 2 parts of isononyl isononanoate, 5 parts of dimethyl silicone polymer, 0.2 part of tocopherol acetate, 0.5 part of carbomer, 5 parts of glycerol, double
Third 10 parts of glycol, 3 parts of propylene glycol, 5 parts of beta glucan, 0.1 part of dipotassium glycyrrhizinate and 0.5 part of aminomethyl propanol.
Above-mentioned functional component and matrix components are made to customization eye cream after mixing.
Comparative example 1
This comparative example provides a kind of eye cream, and functional component distribution ratio is as follows: 5 parts of ceramide, Xylitol-based glucoside
10 parts, 10 parts of anhydro xylitol, 10 parts of xylitol, 1 part of tetrahydro methylpyrimidine carboxylic acid, 10 parts of safflower seed oil, golden button extract
10 parts, 10 parts of Astragalus membranacus root extract, Ubidecarenone part, 10 parts of vitamin E, 5 parts of elastin hydrolysis, Wild soybean albumen 5
Part, 5 parts of dipeptides diaminobutyryl benzyl amide diacetin, 2 parts of kappaphycus algae extract and 2 parts of Caesalpinia spinosaKuntze berry extract；
Matrix components obtain eye cream after mixing with embodiment 2.
Comparative example 2
This comparative example provides a kind of eye cream, and functional component distribution ratio is as follows: 5 parts of ceramide, Xylitol-based glucoside
10 parts, 10 parts of anhydro xylitol, 10 parts of xylitol, 1 part of tetrahydro methylpyrimidine carboxylic acid, 10 parts of safflower seed oil, golden button extract
10 parts, 10 parts of Astragalus membranacus root extract, Ubidecarenone part, 10 parts of vitamin E, 5 parts of elastin hydrolysis, Wild soybean albumen 5
Part, 5 parts of dipeptides diaminobutyryl benzyl amide diacetin, 2 parts of kappaphycus algae extract and 2 parts of Caesalpinia spinosaKuntze berry extract；
Matrix components obtain eye cream after mixing with embodiment 3.
Comparative example 3
This comparative example provides a kind of eye cream, and functional component distribution ratio is as follows: 5 parts of ceramide, Xylitol-based glucoside
10 parts, 10 parts of anhydro xylitol, 10 parts of xylitol, 1 part of tetrahydro methylpyrimidine carboxylic acid, 10 parts of safflower seed oil, golden button extract
10 parts, 10 parts of Astragalus membranacus root extract, Ubidecarenone part, 10 parts of vitamin E, 5 parts of elastin hydrolysis, Wild soybean albumen 5
Part, 5 parts of dipeptides diaminobutyryl benzyl amide diacetin, 2 parts of kappaphycus algae extract and 2 parts of Caesalpinia spinosaKuntze berry extract；
Matrix components obtain eye cream after mixing with embodiment 4.
Effect example 8
After subject's first morning and evening clean skin, the eye cream soya bean size of Example 2 and comparative example 1 is applied to eye circumference respectively, real
The eye cream for applying example 2 is applied to right eye eye circumference skin, and the eye cream of comparative example 1 is applied to left eye eye circumference skin, is massaged into absorption；It is tested
After person's second morning and evening clean skin, the eye cream soya bean size of Example 3 and comparative example 2 is applied to eye circumference respectively, and the eye cream of embodiment 3 applies
It smears in right eye eye circumference skin, the eye cream of comparative example 2 is applied to left eye eye circumference skin, is massaged into absorption；Subject's the third morning and evening clean skin
Afterwards, the eye cream soya bean size of Example 4 and comparative example 3 is applied to eye circumference respectively, and the eye cream of embodiment 4 is applied to right eye eye circumference
Skin, the eye cream of comparative example 3 are applied to left eye eye circumference skin, are massaged into absorption.Test subject's first, second and third is distinguished after 8 weeks
Each parameter of eyes periocualr skin, the results are shown in Table 10.
10 subject of table periocualr skin problem parameter statistics after 8 weeks
From above-described embodiment as can be seen that the custom ophthalmic that the method for customizing of eye skin care item provided by the invention is prepared
Frost can effectively alleviate the eye problems of subject, can effectively be improved using preparation method provided by the invention tested
The water content of person's periocualr skin reduces eye circumference wrinkle, alleviates black eye and improves periocualr skin elasticity.From embodiment 2 and comparison
The comparison of example 1, the comparison of embodiment 3 and comparative example 2 and the comparison of embodiment 4 and comparative example 3 can be seen that according to characterization by
The parameter of examination person's eye problems matches the effect of obtaining ingredient and the proportion of functional component is better than matching using unified functional component
The eye cream just obtained, although and can be seen that the eye cream functional component dosage of comparative example offer compared with embodiment from comparative example 1-3
Used in functional component it is more, but do not obtain better skin effect.From the above, it can be seen that eye provided by the present application
The method for customizing of portion's skin care item can be effectively prepared to obtain the eye cream suitable for subject's eye problems.
Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention., rather than its limitations；To the greatest extent
Pipe present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that: its according to
So be possible to modify the technical solutions described in the foregoing embodiments, or to some or all of the technical features into
Row equivalent replacement；And these are modified or replaceed, various embodiments of the present invention technology that it does not separate the essence of the corresponding technical solution
The range of scheme.
Claims (10)
1. a kind of method for customizing of eye skin care item characterized by comprising according to the ginseng of the characterization eye problems of customized objects
Number matching functional component, is then made the eye skin care item comprising the functional component.
2. the method for customizing of eye skin care item according to claim 1, which is characterized in that the eye problems include skin
One or more of water content, skin pigment content, skin elasticity, dermatoglyph degree and skin smoothness.
3. the method for customizing of eye skin care item according to claim 2, which is characterized in that if moisture content of skin≤40C.U,
Match A1 group functional component；If 40C.U < moisture content of skin≤60C.U, A2 group functional component is matched；If moisture content of skin >
60C.U matches A3 group functional component；
Preferably, the A1 group functional component, the A2 group functional component and the A3 group functional component independently include
One or more of ceramide, Xylitol-based glucoside, anhydro xylitol, xylitol；
Preferably, the A1 group component includes: -5 parts of Cer NP, glucoside 5-6 parts Xylitol-based, dehydration in parts by weight
5-6 parts and xylitol 5-6 parts of xylitol；
Preferably, the A2 group component includes: -3 parts of Cer NS, glucoside 3-5 parts Xylitol-based, dehydration in parts by weight
3-5 parts and xylitol 3-5 parts of xylitol；
Preferably, the A3 group component includes: -2 parts of Cer EOS, glucoside 1-3 parts Xylitol-based, dehydration in parts by weight
1-3 parts and xylitol 1-3 parts of xylitol.
4. the method for customizing of eye skin care item according to claim 2, which is characterized in that characterize skin with skin elasticity R2 value
Skin elasticity matches B1 group functional component if value≤0.5 skin elasticity R2；If 0.5 value≤0.7 < skin elasticity R2, B2 group is matched
Functional component；If skin elasticity R2 value > 0.7, B3 group functional component is matched；
Preferably, the B1 group functional component, the B2 group functional component and the B3 group functional component independently include
Tetrahydro methylpyrimidine carboxylic acid, safflower seed oil, golden button extract, Astragalus membranacus root extract, ubiquinone, vitamin E and hydrolysis bullet
One or more of property albumen；
Preferably, the B1 group component include: in parts by weight 0.5-1 parts of tetrahydro methylpyrimidine carboxylic acid, 3-4 parts of safflower seed oil,
3-4 parts of golden button extract, 3-4 parts of Astragalus membranacus root extract, 3-4 parts of ubiquinone, 3-4 parts of vitamin E and elastin hydrolysis
4-5 parts；
Preferably, the B2 group component includes: 0.2-0.5 parts of tetrahydro methylpyrimidine carboxylic acid, safflower seed oil 2-3 in parts by weight
Part, golden 2-3 parts of button extract, 2-3 parts of Astragalus membranacus root extract, 2-3 parts of ubiquinone, 2-3 parts of vitamin E and hydrolyzed elastin
2-4 parts of albumen；
Preferably, the B3 group component includes: 0.1-0.2 parts of tetrahydro methylpyrimidine carboxylic acid, safflower seed oil 1-2 in parts by weight
Part, golden 1-2 parts of button extract, 1-2 parts of Astragalus membranacus root extract, 1-2 parts of ubiquinone, 1-2 parts of vitamin E and hydrolyzed elastin
1-2 parts of albumen.
5. the method for customizing of eye skin care item according to claim 2, which is characterized in that with dermal melanin content MI value
Skin pigment content is characterized, if dermal melanin content MI value > 200, matches C1 group functional component；If dermal melanin content
Value≤200 MI match C2 group functional component；
Preferably, the C1 group component in parts by weight include: 3-4 parts of Wild soybean albumen, it is glucoside 1-3 parts Xylitol-based, de-
1-3 parts and xylitol 1-3 parts of water xylitol；
Preferably, the C2 group component in parts by weight include: 1-3 parts of Wild soybean albumen, it is glucoside 1-3 parts Xylitol-based, de-
1-3 parts and xylitol 1-3 parts of water xylitol.
6. the method for customizing of eye skin care item according to claim 2, which is characterized in that characterize skin with canthus line area
Texture, if canthus line area is > 20mm2, match D1 group functional component；If 15mm2The canthus < line area≤20mm2, matching
D2 group functional component；If canthus line area≤15mm2, match D3 group functional component；
Preferably, the D1 group component includes:, 3-5 parts of dipeptides diaminobutyryl benzyl amide diacetin, grows in parts by weight
0.5-1 parts of heart Kappa algae extract, 0.5-1 parts of Caesalpinia spinosaKuntze berry extract, 3-5 parts of safflower seed oil, golden 3-5 parts of button extract,
3-5 parts of Astragalus membranacus root extract, 3-5 parts of ubiquinone and 3-5 parts of vitamin E；
Preferably, the D2 group component includes: 2-3 parts of dipeptides diaminobutyryl benzyl amide diacetin, length in parts by weight
0.3-0.5 parts of heart Kappa algae extract, 0.3-0.5 parts of Caesalpinia spinosaKuntze berry extract, 2-3 parts of safflower seed oil, golden button extract 2-3
Part, 2-3 parts of Astragalus membranacus root extract, 2-3 parts of ubiquinone and 2-3 parts of vitamin E；
Preferably, the D3 group component includes: 1-2 parts of dipeptides diaminobutyryl benzyl amide diacetin, length in parts by weight
0.1-0.3 parts of heart Kappa algae extract, 0.1-0.3 parts of Caesalpinia spinosaKuntze berry extract, 1-2 parts of safflower seed oil, golden button extract 1-2
Part, 1-2 parts of Astragalus membranacus root extract, 1-2 parts of ubiquinone and 1-2 parts of vitamin E.
7. the method for customizing of eye skin care item according to claim 1 to 6, which is characterized in that by described effect
The eye skin care item are made in ingredient after mixing with matrix components；
Preferably, the matrix components include moisturizer, surfactant, thickener, dispersing agent, antioxidant, flavouring agent, moisturizing
One or more of agent, anti-allergic agent, pH adjusting agent, filler, carrier and solvent.
8. the method for customizing of eye skin care item according to claim 7, which is characterized in that in parts by weight, the matrix
Ingredient includes: 1-2 parts of cetostearyl alcohol, 1-2 parts of cocoyl glucoside, 1-3 parts of stearine, PEG-100 stearate
1-3 parts, 1-3 parts of Sucrose Polystearic Acid Esters, 1-3 parts of Parleam, 1-3 parts of cetanol, 1-3 parts of stearyl alcohol, oleyl alcohol erucic acid
2-5 parts of ester, 2-5 parts of isononyl isononanoate, 2-5 parts of dimethyl silicone polymer, 0.2-1 parts of tocopherol acetate, carbomer 0.1-
0.5 part, 5-10 parts of glycerol, 5-10 parts of dipropylene glycol, 3-5 parts of propylene glycol, 3-5 parts of beta glucan, 0.1-0.5 parts of dipotassium glycyrrhizinate
With 0.1-0.5 parts of aminomethyl propanol.
9. the method for customizing of eye skin care item according to claim 1 to 6, which is characterized in that the eye shield
Skin product include eye cream, lotion, essence, toner or eye mask.
10. a kind of eye maintenance method, which is characterized in that of any of claims 1-9 described the method includes using
The skin care item nursing eye circumference skin that the preparation method of customization eye skin care item is prepared.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811400907.1A CN109223602A (en) | 2018-11-22 | 2018-11-22 | The method for customizing of eye skin care item and eye maintenance method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811400907.1A CN109223602A (en) | 2018-11-22 | 2018-11-22 | The method for customizing of eye skin care item and eye maintenance method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109223602A true CN109223602A (en) | 2019-01-18 |
Family
ID=65075905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811400907.1A Pending CN109223602A (en) | 2018-11-22 | 2018-11-22 | The method for customizing of eye skin care item and eye maintenance method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109223602A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109820782A (en) * | 2019-03-21 | 2019-05-31 | 伯德创研(广州)生物科技有限公司 | A kind of microemulsion-type anti-wrinkle essence and preparation method thereof |
| CN112137949A (en) * | 2019-06-27 | 2020-12-29 | 东莞圣幸健康科技有限公司 | Firming and anti-aging composition, application thereof and firming and anti-aging mask |
| CN112472637A (en) * | 2019-10-09 | 2021-03-12 | 广东丸美生物技术股份有限公司 | Firming essence containing Kappaphycus alvarezii extract and preparation method thereof |
| CN112603867A (en) * | 2021-01-04 | 2021-04-06 | 广东名兰化妆品制造有限公司 | Skin membrane repairing essence stock solution and preparation method thereof |
| CN113786361A (en) * | 2021-09-26 | 2021-12-14 | 湖北省麦诗特生物科技有限公司 | Eye cream composition with pouch removing effect and preparation method thereof |
| CN113797127A (en) * | 2021-08-31 | 2021-12-17 | 珀莱雅化妆品股份有限公司 | Plant fermentation product with anti-dark eye effect and preparation method thereof |
| CN114712251A (en) * | 2022-03-18 | 2022-07-08 | 广东丸美生物技术股份有限公司 | Moisturizing and anti-wrinkle eye cream and preparation method thereof |
| CN114948802A (en) * | 2022-04-12 | 2022-08-30 | 露乐健康科技股份有限公司 | Skin care composition for improving poor skin state of people with sleep deficiency, preparation method thereof and skin care product |
| CN117122536A (en) * | 2023-08-28 | 2023-11-28 | 上海炫美生物科技有限公司 | Efficient repairing composition and anti-sensitization cosmetic |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101432748A (en) * | 2006-09-18 | 2009-05-13 | 阿拉姆胡维斯有限公司 | Method for providing customized cosmetics and system for the same |
-
2018
- 2018-11-22 CN CN201811400907.1A patent/CN109223602A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101432748A (en) * | 2006-09-18 | 2009-05-13 | 阿拉姆胡维斯有限公司 | Method for providing customized cosmetics and system for the same |
Non-Patent Citations (4)
| Title |
|---|
| 周为群等: "《现代生活与化学》", 31 May 2016, 苏州大学出版社 * |
| 戴晓钟等: "《中国科学美容大典》", 28 February 2002, 人民军医出版社 * |
| 陈明宏: "《珍珠美极了》", 31 August 2008, 广东科技出版社 * |
| 雷万军等: "《皮肤美容学基础与应用》", 31 December 2013, 中国中医药出版社 * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109820782A (en) * | 2019-03-21 | 2019-05-31 | 伯德创研(广州)生物科技有限公司 | A kind of microemulsion-type anti-wrinkle essence and preparation method thereof |
| CN109820782B (en) * | 2019-03-21 | 2021-09-10 | 伯德创研(广州)生物科技有限公司 | Microemulsion type wrinkle-removing essence and preparation method thereof |
| CN112137949A (en) * | 2019-06-27 | 2020-12-29 | 东莞圣幸健康科技有限公司 | Firming and anti-aging composition, application thereof and firming and anti-aging mask |
| CN112472637A (en) * | 2019-10-09 | 2021-03-12 | 广东丸美生物技术股份有限公司 | Firming essence containing Kappaphycus alvarezii extract and preparation method thereof |
| CN112603867A (en) * | 2021-01-04 | 2021-04-06 | 广东名兰化妆品制造有限公司 | Skin membrane repairing essence stock solution and preparation method thereof |
| CN113797127A (en) * | 2021-08-31 | 2021-12-17 | 珀莱雅化妆品股份有限公司 | Plant fermentation product with anti-dark eye effect and preparation method thereof |
| CN113797127B (en) * | 2021-08-31 | 2023-03-03 | 珀莱雅化妆品股份有限公司 | Plant fermentation product with black eye resisting effect and preparation method thereof |
| CN113786361A (en) * | 2021-09-26 | 2021-12-14 | 湖北省麦诗特生物科技有限公司 | Eye cream composition with pouch removing effect and preparation method thereof |
| CN113786361B (en) * | 2021-09-26 | 2024-01-26 | 湖北省麦诗特生物科技有限公司 | Eye cream composition with pouch removing effect and preparation method thereof |
| CN114712251A (en) * | 2022-03-18 | 2022-07-08 | 广东丸美生物技术股份有限公司 | Moisturizing and anti-wrinkle eye cream and preparation method thereof |
| CN114948802A (en) * | 2022-04-12 | 2022-08-30 | 露乐健康科技股份有限公司 | Skin care composition for improving poor skin state of people with sleep deficiency, preparation method thereof and skin care product |
| CN117122536A (en) * | 2023-08-28 | 2023-11-28 | 上海炫美生物科技有限公司 | Efficient repairing composition and anti-sensitization cosmetic |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109223602A (en) | The method for customizing of eye skin care item and eye maintenance method | |
| Czajka et al. | Daily oral supplementation with collagen peptides combined with vitamins and other bioactive compounds improves skin elasticity and has a beneficial effect on joint and general wellbeing | |
| Schwartz et al. | Ingestion of BioCell Collagen®, a novel hydrolyzed chicken sternal cartilage extract; enhanced blood microcirculation and reduced facial aging signs | |
| Schunck et al. | Dietary supplementation with specific collagen peptides has a body mass index-dependent beneficial effect on cellulite morphology | |
| CN106998780B (en) | Composition for improving skin containing pomegranate concentrate as active ingredient | |
| JP5661994B2 (en) | Composition or internal preparation with anti-stress / fatigue prevention, skin texture improvement or wrinkle improvement / prevention effect | |
| KR102450173B1 (en) | Cosmetic composition for moisturizing facial skin and alleviating swelling | |
| CN116076741A (en) | Oral cosmetic composition containing collagen peptide and EGCG and application thereof | |
| Dąbrowska et al. | Noninvasive evaluation of the influence of aucubin‐containing cosmetic macroemulsion on selected skin parameters | |
| JP2020503382A (en) | Composition for improving atopic skin symptoms containing poly-gamma-glutamic acid | |
| RU2491022C1 (en) | Method of correcting dehydrated involutionally changed face skin in women | |
| KR20120017987A (en) | Cosmetic composition for improving wrinkles around the eyes | |
| Tulina et al. | Evaluation of the in vivo cosmetic efficacy of the MF3 blue cell serum gel. One‐and two‐month test results | |
| KR20140012091A (en) | Composition comprising banyan tree, lotus, and clover serum fractions (hyperpigmentation) | |
| CN108703917B (en) | Anti-aging composition and cosmetic prepared from same | |
| KR101738339B1 (en) | Composition for improving skin aging and wrinkle comprising herbal medicine mixed extract as effective component | |
| KR101933152B1 (en) | Composition for improving skin condition comprising pomegranate concentrate as active ingredient | |
| CN108888561A (en) | A kind of lightening compositions and its cosmetics of preparation | |
| KR101927826B1 (en) | Composition for improving skin condition comprising pomegranate concentrate as active ingredient | |
| KR20110082227A (en) | Skin color evaluation method and method of providing skin counseling information based on the same | |
| Vasylyeva et al. | Application of hyaluronic acid in skin care of women in perimenopausal and menopausal periods | |
| Trehan et al. | Efficacy and Safety of Skin Radiance Collagen on Skin and Hair Matrix: A Placebo-Controlled Clinical Trial in Healthy Human Subjects | |
| US20250177285A1 (en) | Banana stem sap compositions and methods of use thereof | |
| CN102670477A (en) | Collagen skincare product for improving skin | |
| TWI797367B (en) | Use of silkworm extract composition as skin care and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190118 |